ASXL1 and Buschke-Ollendorff syndrome: Our previous work studying BOS patient-derived samples, which harbor germline ASXL1 variants, found that many epigenetic and transcriptomic changes are cell-type specific, but there are clear disruptions that are shared across ASXL1-mutated cells, such as dysregulation of the Wnt-signaling pathways [28].